This model also predicted that the subpopulation of tumor endothelial cells expressing >35,000 VEGFR1/cell is a potential marker of therapeutic resistance to the anti-VEGF treatment (Weddell and Imoukhuede, 2014). Here, FLT1 is linked to neoplasm.